Out-of-Pocket Cost Increase Could Put HIV Prevention Medications out of Reach
Penn Medicine News
From Penn Medicine News:
The analysis also highlighted the negative consequences of abandoning PrEP: The rate of new HIV infections in the year after the initial PrEP prescription was two to three times higher among those who never filled those prescriptions.
“Our findings suggest that out-of-pocket cost increases for PrEP could upend the progress that has been made towards ending the HIV/AIDS epidemic in the United States,” said study senior author Jalpa Doshi, PhD, a professor of Medicine and the director of Value-based Insurance Design Initiatives at the Center for Health Incentives and Behavioral Economics at Penn Medicine.